Navigation Links
ChromaDex® Announces Letter of Intent Signed with Glanbia Nutritionals for Partnership on pTeroPure®
Date:1/24/2012

y strong company like Glanbia is a tremendous next step in expanding pTeroPure's adoption into numerous consumer products. With our upcoming human clinical data release and our various patents pending, in combination with Glanbia's strong distribution base, we are now very well-positioned to more rapidly accelerate our national expansion of pTeroPure," said William Spengler, President of ChromaDex.

"ChromaDex's pTeroPure is an excellent addition to our product portfolio due to its superior bioavailability and range of potential health benefits," said Richard Hazel, CEO of Glanbia Nutritionals (NA), Inc. "The new distribution agreement will allow us to utilize our extensive market experience and national sales resources towards promoting ChromaDex's innovative new product line and will benefit Glanbia Nutritionals by strengthening our position as a leader in the ingredients industry."

About Glanbia Nutritionals (NA), Inc.:

Glanbia Nutritionals is a division of Glanbia plc, an international nutritional solutions and cheese group, headquartered in Kilkenny, Ireland. The Group has 4,300 employees worldwide, with operations in Ireland, the UK, Germany, USA, Canada, Mexico and China, as well as strategic international joint ventures in the UK, USA and Nigeria. Glanbia is listed on both the Dublin and London Stock Exchange. Glanbia is a global supplier of nutritional ingredients, functional ingredients and customized premix solutions. Glanbia Nutritionals is on the forefront in the exploration of science and the dynamics that drive the growing nutrition industry. For more information visit glanbianutritionals.com or contact Thomas Monroe, Marketing, 760-438-0089, tmonroe@glanbia.com.

About ChromaDex®:

ChromaDex, Inc. is an innovative natural products company that provides proprietary, science-based solutions and ingredients to the die
'/>"/>

SOURCE ChromaDex Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. ChromaDex®s Novel Ingredient pTeroPure® to be Studied as Potential Treatment for Fighting Skin Cancers
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 Reaching a critical milestone in ... Association of Boards of Pharmacy ® (NABP ® ... suffix has passed the Internet Corporation for Assigned Names ... the .PHARMACY gTLD by the end of 2013, and ... pharmacies and related entities that are located in ...
(Date:5/21/2013)... Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: ... solution provider and operator of the largest network of ... parent of Chang,an Hospital, today reported its unaudited consolidated ... 2013 [1] . First Quarter 2013 Highlights ... revenues generated from the network business and hospital business, ...
(Date:5/21/2013)... Mass. , May 21, 2013  NxStage Medical, ... of innovative dialysis products, today announced that it has ... critical care and in-center products to DaVita, the kidney ... http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) For the use ... United States , NxStage has executed a second ...
Breaking Medicine Technology:NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 2NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 3Concord Medical Reports First Quarter 2013 Financial Results 2Concord Medical Reports First Quarter 2013 Financial Results 3Concord Medical Reports First Quarter 2013 Financial Results 4Concord Medical Reports First Quarter 2013 Financial Results 5Concord Medical Reports First Quarter 2013 Financial Results 6Concord Medical Reports First Quarter 2013 Financial Results 7Concord Medical Reports First Quarter 2013 Financial Results 8Concord Medical Reports First Quarter 2013 Financial Results 9Concord Medical Reports First Quarter 2013 Financial Results 10Concord Medical Reports First Quarter 2013 Financial Results 11Concord Medical Reports First Quarter 2013 Financial Results 12Concord Medical Reports First Quarter 2013 Financial Results 13NxStage Announces New Agreements with DaVita 2
... July 25, 2011 Prasco Laboratories, the Authorized Generics company, ... Shionogi Inc . Under the terms of the agreement, ... USP 250 mg, the Authorized Generic version of Ponstel ... in the U.S. under the Prasco label. "With ...
... 25, 2011 Cornerstone Pharmaceuticals, Inc., ( www.cornerstonepharma.com ... cancer metabolism-based therapeutics, today announced the publication of ... Medicine ( http://tinyurl.com/3ugohzd ) describing the selective ... novel lipoate derivative compounds.  Specifically, the publication illuminates ...
Cached Medicine Technology:Prasco® Announces Authorized Generic Agreement with Shionogi Inc. 2Cornerstone Pharmaceuticals Announces The Journal of Molecular Medicine's Publication of Research Showing Selective Inhibition of Cancer Cell Energy Metabolism With Its Novel Lipoate Derivative Compounds 2Cornerstone Pharmaceuticals Announces The Journal of Molecular Medicine's Publication of Research Showing Selective Inhibition of Cancer Cell Energy Metabolism With Its Novel Lipoate Derivative Compounds 3Cornerstone Pharmaceuticals Announces The Journal of Molecular Medicine's Publication of Research Showing Selective Inhibition of Cancer Cell Energy Metabolism With Its Novel Lipoate Derivative Compounds 4
(Date:5/21/2013)... George Washington (GW) University School of Public ... launch of the Avance Center for the ... SPHHS, the Maryland Multicultural Youth Centers, the ... university-community partnership aims to address public health ... research, mutual capacity building and prevention efforts. ...
(Date:5/21/2013)... Daily Gossip Magazine published well-documented articles that are meant to ... on the latest weight loss methods by publishing weekly in-depth ... review of Kyle Leon’s Customized Fat Loss Plan ... lose weight or stay in shape with the minimum effort. ... by a popular fitness trainer, Kyle Leon, who has made ...
(Date:5/21/2013)... TX (PRWEB) May 21, 2013 Medical ... with the prestigious 2013 Top-Rated Award by GreatNonprofits , ... “We are excited to be named a Top-Rated 2013 Nonprofit,” ... without the dedication of our over 3000 Volunteers and Staff ... especially significant as it came from those that have seen ...
(Date:5/21/2013)... GA (PRWEB) May 21, 2013 Patients of ... Care who have lost teeth due to gum disease and ... surgery for gum disease treatment with laser gum surgery. ... which have the highest success rate out of all tooth ... (LANAP) is a relatively new procedure cleared by the Food ...
(Date:5/21/2013)... San Diego, CA (PRWEB) May 21, 2013 ... and adding materials showing how to use 17 DISC ... certification is a natural progression. , The July ... will feature the top 17 ways of applying DISC. ... from DISC certified graduates. The user-friendly DISC training ...
Breaking Medicine News(10 mins):Health News:GW launches center to address health disparities in the Latino immigrant community 2Health News:GW launches center to address health disparities in the Latino immigrant community 3Health News:Customized Fat Loss Plan Review and Diet Secrets Revealed By Daily Gossip Magazine 2Health News:Medical Ministry International Recognized as a 2013 Top-rated Nonprofit By GreatNonprofits.org 2Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4
... PHILADELPHIA Researchers at the University of Pennsylvania School of ... that maintain the proper level of bile in the liver. ... diseases that involve the regulation of bile salts. The study ... , Bile, although made in the liver, is stored in ...
... for enhancing athletic performance and muscle strength, does ... obstructive pulmonary disease (COPD), according to a new ... most powerful evidence to date that the effect ... among these patients. , "We have evidence to ...
... year in a row, is giving away $1 million in discount ... , ... Norwalk, CT (PRWEB) August 1, 2008 -- ... Incorporated], a leading consumer services marketing company, and Coverdell and Company, ...
... Bad Backs Essential Shoulder Brace is a comfortable, wear-anywhere posture support/brace, ... and neck pain.,With people spending increasing amounts of time working at ... Australian designed product has been made for comfort and can be ... ...
... important conference at its Rhinebeck campus August 15-17, for professionals and ... development in treating and living with autism. , ... ... consecutive year, Omega Institute will host an important conference at its ...
... /Xinhua-PRNewswire/ -,-- ... ... PharmaTech (NYSE: WX ), a leading pharmaceutical, biotechnology and ... today announced that it has appointed Mr. Steven M. Hutchins as,Vice President of ...
Cached Medicine News:Health News:Penn researchers find a new role for a 'Foxy Old Gene' 2Health News:No substitute for hard work: Creatine supplementation does not improve exercise outcomes in COPD 2Health News:Vertrue Incorporated and Feed The Children Join Forces to Give Away $1 Million in Aid to Families in Need 2Health News:Vertrue Incorporated and Feed The Children Join Forces to Give Away $1 Million in Aid to Families in Need 3Health News:Vertrue Incorporated and Feed The Children Join Forces to Give Away $1 Million in Aid to Families in Need 4Health News:Bad Backs Essential Shoulder Brace - Now Available at badbackstore.com 2Health News:Bad Backs Essential Shoulder Brace - Now Available at badbackstore.com 3Health News:Bad Backs Essential Shoulder Brace - Now Available at badbackstore.com 4Health News:Omega to Hold Conference: Autism Through the Life Span II 2Health News:Omega to Hold Conference: Autism Through the Life Span II 3Health News:WuXi PharmaTech (NYSE: WX) Appoints Mr. Steven M. Hutchins as VP of Business Development 2
... a high throughput primary or backup ... offers performance and reliability equal to ... instruments. The advanced technology of the ... strips delivers reproducible and accurate results, ...
... for the World Health Organization as a ... been widely used in clinical trials and ... methods. Urine samples are diluted in buffer ... (enzyme labelled immunoassay with magnetic second antibody ...
... Estrone Enzyme Immunosorbent Assay (EIA) Kit ... of Estrone in serum. The procedure ... immunoassay where there is competition between ... antigen for a fixed number of ...
... Helmer presents the ... with innovative solutions for ... more sophisticated features than ... Bank Refrigerators are at ...
Medicine Products: